Assembly Biosciences, Inc.

The current price of ASMB is $20.00 — it has increased by 0.65% since the previous close. Data as of Nov 5, 2026.

ASMB is down 4.12% over the past week, down 12.05% over the past month and down 37.71% over the past year. The price is below its 200-day moving average of $27.06.

Analysts' average 12-month price target for ASMB is $51.67, which implies 158.35% upside from the current price. Individual estimates range from $50.00 to $53.00.

Of the 5 analysts covering Assembly Biosciences, Inc., 5 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Assembly Biosciences, Inc. has a market capitalization of $407.21M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Assembly Biosciences, Inc. posted a loss of $0.20 per share against an estimate of -$0.7242, beating expectations by 72.38%. Upcoming reports are listed in the earnings calendar.

Assembly Biosciences, Inc. reported revenue of $13.37M in its most recent quarter, which has increased by 38.94% compared with the same quarter a year earlier. Analysts had expected $8.6M.

Assembly Biosciences, Inc. has not paid any dividends over the past year.

Companies most comparable to Assembly Biosciences, Inc. include Vir Biotechnology, Inc., Arbutus Biopharma Corp, Indaptus Therapeutics, Inc., Atea Pharmaceuticals, Inc. and Enanta Pharmaceuticals, Inc.

In the latest trading session ASMB moved between $19.20 and $20.06, a range of 4.30% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Assembly Biosciences, Inc. shows a sell rating today. Technical ratings are indicators, not investment advice.

Over the past 52 weeks ASMB has traded between $19.20 and $39.71. The current price is 49.63% below its 52-week high.